Late direct and transneuronal effects in mice with targeted expression of a toxin gene to D1 dopamine receptor neurons

Neuroscience

Volumn 95, Issue 4, 1999, Pages 1035-1041

  Wong, J Y F ^a   Padungchaichot, P ^a   Massalas, J S ^a   Drago, J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Dynorphin; Enkephalin; Knockout; Muscarinic receptor; Substance P

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DIPHTHERIA TOXIN; DOPAMINE 1 RECEPTOR; DOPAMINE TRANSPORTER; DYNORPHIN; ENKEPHALIN; MAZINDOL; MESSENGER RNA; MUSCARINIC RECEPTOR; SUBSTANCE P; SULPIRIDE; VESICULAR ACETYLCHOLINE TRANSPORTER;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN DEVELOPMENT; BRAIN INJURY; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; HUNTINGTON CHOREA; HYPERKINESIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LOCOMOTION; MOTOR DYSFUNCTION; MOUSE; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL;

ANIMALS; ANIMALS, NEWBORN; AUTORADIOGRAPHY; CARRIER PROTEINS; DIPHTHERIA TOXIN; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DYNORPHINS; ENKEPHALINS; GENE EXPRESSION; GENE TARGETING; KANAMYCIN KINASE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NEURONS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, MUSCARINIC; RNA, MESSENGER; SUBSTANCE P;

EID: 0033405157     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00498-4     Document Type: Article

References (28)

1. Alvarez-Bolado G., Fairen A., Douglass J., Naranjo J.R. Expression of the prodynorphin gene in the developing and adult cerebral cortex of the rat: an in situ hybridization study. J. comp. Neurol. 300:1990;287-300.
2. Andrews T. C., Weeks R. A., Turjanski N. and Brooks D. J. (1998) Monitoring disease progression in presymptomatic and early Huntington's disease: D1 and D2 ligand PET and the unified Huntington's disease rating scale. Abstract of the American Academy of Neurology, Minneapolis, MN. S50.002.
3. Creese I., Usdin T., Snyder S.H. Guanine nucleotides distinguish between two dopamine receptors. Nature. 278:1979;577-578.
4. Daly S.A., Waddington J.L. Two directions of dopamine D1/D2 receptor interaction in studies of behavioural regulation: a finding generic to four new, selective dopamine D1 receptor antagonists. Eur. J. Pharmac. 213:1992;251-258.
5. Deveney A.M., Waddington J.L. Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213. Psychopharmacology. 124:1996;40-49.
6. Drago J., Gerfern C.R., Lachowicz J.E., Steiner H., Hollon T.R., Love P.E., Ooi G.T., Grinberg A., Lee E.J., Huang S.P., Bartlett P.F., Jose P.A., Sibley D.R., Westphal H. Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc. natn. Acad. Sci. U.S.A. 91:1994;12564-12568.
7. Drago J., Padungchaichot P., Wong J.Y.F., Lawrence A.J., McManus J.F., Sumarsono S.H., Natoli A.L., Lakso M., Wreford N., Westphal H., Kola I., Finkelstein D.I. Targeted expression of a toxin gene to D1 dopamine receptor neurons by Cre-mediated site-specific recombination. J. Neurosci. 18:1998;9845-9857.
8. 3H]-sulpiride. Eur. J. Pharmac. 138:1987;61-68.
9. Garau L., Govoni S., Stefanini E., Trabucchi M., Spano P.F. Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum. Life Sci. 23:1978;1745-1750.
10. Ginovart N., Lundin A., Farde L., Halldin C., Backman L., Swahn C.G., Pauli S., Sedvall G. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain. 120:1997;503-514.
11. A receptor binding. Eur. J. Pharmac. 309:1996;115-120.
12. Harlan R.E., Garcia M.M., Krause J.E. Cellular localization of substance P- and neurokinin A-encoding preprotachykinin mRNA in the female rat brain. J. comp. Neurol. 287:1989;179-212.
13. Ince E., Ciliax B.J., Levey A.I. Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons. Synapse. 27:1997;357-366.
14. Jones E.G., Hendry S.H.C. Co-localisation of GABA and neuropeptides in neocortical neurons. Trends Neurosci. 9:1986;71-76.
15. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., Bates G.P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87:1996;493-506.
16. 3H]-glutamic acid release by dopaminergic drugs. Life Sci. 26:1980;2073-2081.
17. Murray A.M., Waddington J.L. Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502. Psychopharmacology. 98:1989;245-250.
18. Nance M.A. Huntington disease: clinical, genetic, and social aspects. J. geriat. Psychiat. Neurol. 11:1998;61-70.
19. Padungchaichot P., Wong J.Y.F., Natoli A.L., Massalas J.S., Finkelstein D.I., Lawrence A.L., Drago J. Early direct and transneuronal effects in mice with targeted expression of a toxin gene to D1 dopimine receptor neurons. Neuroscience. 95:2000;000-000.
20. Rowlands G.F., Roberts P.J. Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico-striatal terminals in vitro. Eur. J. Pharmac. 62:1980;241-242.
21. Sato M., Morita Y., Saika T., Fujita M., Ohhata K., Tohyama M. Localization and ontogeny of cells expressing preprodynorphin mRNA in the rat cerebral cortex. Brain Res. 541:1991;41-49.
22. Schwarcz R., Creese I., Coyle J.T., Snyder S.H. Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum. Nature. 271:1978;766-768.
23. Steiner H., Gerfen C.R. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Expl Brain Res. 123:1998;60-76.
24. 11C]SCH-23390. Abstract of the American Academy of Neurology. Minneapolis, MN. S50.003.
25. 3H]sulpiride binding in rats, so D-2 receptors exist post-synaptically on corticostriate afferents and striatal neurons. J. Pharm. Pharmac. 33:1981;439-444.
26. Warden M.K., Young W.S.D. Distribution of cells containing mRNAs encoding substance P and neurokinin B in the rat central nervous system. J. comp. Neurol. 272:1988;90-113.
27. Warenycia M.W., McKenzie G.M., Murphy M., Szerb J.C. The effects of cortical ablation on multiple unit activity in the striatum following dexamphetamine. Neuropharmacology. 26:1987;1107-1114.
28. Wong J.Y.F., Liberatore G.T., Donnan G.A., Howells D.W. Expression of brain-derived neurotrophic factor and TrkB neurotrophin receptors after striatal injury in the mouse. Expl Neurol. 148:1997;83-91.